antitrust

Antitrust laws are designed to protect competition and prevent monopolies. In the health care industry, antitrust laws can be used to challenge mergers and acquisitions that could reduce competition and lead to higher prices. However, antitrust cases can be complex and expensive, and it is often difficult to prove that a company has violated antitrust laws.

Articles on this page concern hospital consolidation, pharma mergers, and drug pricing as it relates to the availability of cheaper, generic versions.

All Coverage

Pharmalot Ed Silverman

Most Read

STAT Plus: Pharmalittle: Opioid settlements may yield tax breaks for drug makers; EMA probes heartburn meds for carcinogens

STAT Plus: Consumer groups and unions urge FTC to block AbbVie and Allergan merger

STAT Plus: Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says

STAT Plus: Johnson & Johnson is fined $30 million for thwarting generics in France

STAT Plus: FTC probes Mylan for possible antitrust violations involving EpiPen

STAT Plus: Drug makers are sued for scheming to illegally fix insulin prices

STAT Plus: Two former pharma execs first to be charged in generic price-fixing probe

Pharmalot, Pharmalittle: FTC is ‘aware’ of concerns over possible Mylan antitrust violations

All Coverage

Lawmakers call for FTC probe into potential antitrust violations in EpiPen school program

FTC seeks review of a court ruling on generic drug competition

Drug maker fined for shorting supplies of cancer drugs in order to raise prices

STAT Plus: Senator urges FTC to step up investigation into maker of addiction treatment

Mylan may have violated antitrust law in its EpiPen sales to schools, legal experts say

STAT Plus: Glaxo, other drug makers appeal UK fines for pay-to-delay deals

Pfizer fined by UK regulator amid pricing probe

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day

Subscribe to STAT+ for less than $2 per day

Become a STAT+ subscriber today!